Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.

OBJECTIVE: Therapies that deplete lymphocytes often improve symptoms in patients with otherwise refractory autoimmune disease but may result in long-term lymphopenia, the consequences of which are uncertain. To assess the impact of prolonged lymphopenia on morbidity and mortality, we studied patien...

書誌詳細
主要な著者:	Isaacs, J, Greer, S, Sharma, S, Symmons, D, Smith, M, Johnston, J, Waldmann, H, Hale, G, Hazleman, B
フォーマット:	Journal article
言語:	English
出版事項:	2001

類似資料

Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes.
著者:: Lorenzi, A, 等
出版事項: (2008)

Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: comment on the article by Isaacs et al - Reply
著者:: Isaacs, J, 等
出版事項: (2002)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
著者:: Isaacs, J, 等
出版事項: (2004)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
著者:: Isaacs, J, 等
出版事項: (2005)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
著者:: Isaacs, J, 等
出版事項: (2005)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
著者:: Isaacs, J, 等
出版事項: (1992)

TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H
著者:: Watts, R, 等
出版事項: (1992)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA.
著者:: Isaacs, J, 等
出版事項: (1998)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
著者:: Isaacs, J, 等
出版事項: (1992)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
著者:: Kyle, V, 等
出版事項: (1991)

CAMPATH-1H in inflammatory arthritis.
著者:: Watts, R, 等
出版事項: (1993)

Lymphopenia predicts 30-day morbidity and mortality following spinal metastasis surgery
著者:: Pedro Reggiani Anzuatégui, 等
出版事項: (2021-06-01)

Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.
著者:: Kyle, V, 等
出版事項: (1989)

Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
著者:: Lawson, C, 等
出版事項: (2005)

A pilot study of combination anti-cytokine and anti-lymphocyte biological therapy in rheumatoid arthritis.
著者:: Morgan, A, 等
出版事項: (2008)

Combination therapy with a TNF antagonist and a CD4 monoclonal antibody in rheumatoid arthritis. A pilot study.
著者:: Morgan, A, 等
出版事項: (1997)

Commentary: Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis
著者:: Thomas J Wilkinson
出版事項: (2015-12-01)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
著者:: Isaacs, J, 等
出版事項: (1996)

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans.
著者:: Isaacs, J, 等
出版事項: (1996)

Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis
著者:: Kayo eMasuko
出版事項: (2014-11-01)

Lymphopenia in diverticulitis.
著者:: Baker, SR, 等
出版事項: (1991)

Reprogramming the immune system: a possible therapeutic approach to established autoimmune disease.
著者:: Waldmann, H, 等
出版事項: (1993)

Is Lymphopenia a Predictor of Mortality in Patients with COVID-19?
著者:: Jehat Kılıc, 等
出版事項: (2023-01-01)

Genetic Study of Severe Prolonged Lymphopenia in Multiple Sclerosis Patients Treated With Dimethyl Fumarate
著者:: Dipen Sangurdekar, 等
出版事項: (2019-11-01)

Patterns and prevalence of psychiatric morbidity among individuals with rheumatoid arthritis
著者:: Ajaz Kariem Khan, 等
出版事項: (2024-04-01)

Lymphopenia in hospitalized patients and its relationship with severity of illness and mortality.
著者:: Juan Carlos Andreu-Ballester, 等
出版事項: (2021-01-01)

Morbidity and mortality in patients with rheumatoid arthritis compared with an age- and sex-matched control population: A nationwide register study
著者:: Katrine Løppenthin, 等
出版事項: (2019-05-01)

Association of lymphopenia and RDW elevation with risk of mortality in acute aortic dissection
著者:: Dan Yu, 等
出版事項: (2023-01-01)

Association of lymphopenia and RDW elevation with risk of mortality in acute aortic dissection.
著者:: Dan Yu, 等
出版事項: (2023-01-01)

LYMPHOPENIA: THE MAIN CAUSES
著者:: N. T. Vatutin, 等
出版事項: (2016-05-01)

Prolonged lymphopenia and prognoses among inpatients with different respiratory virus infections: A retrospective cohort study
著者:: Guohui fan, 等
出版事項: (2024-06-01)

Editorial: Updates on radiation-induced lymphopenia
著者:: Pim J. J. Damen, 等
出版事項: (2024-07-01)

Profound Alkalosis and Prolonged QT Interval Due to Inappropriate Gastrostomy Tube Loss: A Case Report
著者:: Forrest Turner, 等
出版事項: (2024-04-01)

A multicenter, randomized, placebo‐controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis
著者:: Kitas, G, 等
出版事項: (2019)

Rheumatoid arthritis association at 6q23.
著者:: Thomson, W, 等
出版事項: (2007)

THE STATE OF HEALTH OF ADOLESCENTS WITH INFANTILE CEREBRAL PARALYSIS: MORBIDITY ACCORDING TO THE DATA OF PROFOUND EXAMINATION
著者:: Z.M. Aminova, 等
出版事項: (2009-05-01)

THE STATE OF HEALTH OF ADOLESCENTS WITH INFANTILE CEREBRAL PARALYSIS: MORBIDITY ACCORDING TO THE DATA OF PROFOUND EXAMINATION
著者:: Z.M. Aminova, 等
出版事項: (2009-01-01)

Towards Personalized Medicine in Rheumatoid Arthritis
著者:: Sharma SD, 等
出版事項: (2024-05-01)

Radio source extraction with ProFound
著者:: Hale, C, 等
出版事項: (2019)

Keratinocyte growth factor impairs human thymic recovery from lymphopenia
著者:: Coles, A, 等
出版事項: (2019)